The Situation
A leading pharmaceutical company sought to strengthen its direct-to-consumer (D2C) strategy across its current portfolio while evaluating expansion into new areas. To support these objectives, the client needed a robust understanding of competitive dynamics across lab services, point-of-care (POC), and self-test offerings—initially focused on Respiratory (including COVID-19, Flu, and RSV) and sexually transmitted infections (STI) in the U.S.
The Solution
Sedulo designed a tailored competitive intelligence program combining comprehensive landscapes, continuous monitoring, primary intelligence, and email flash alerts to deliver validated, decision-ready insights.
- Comprehensive Landscapes and Refreshes
Sedulo delivered a full U.S. landscape for COVID-19, Flu, and RSV competitors, along with landscape snapshots for additional respiratory and STI indications. The executive-ready landscape included market evolution, new entrants, workflows, market share, sales, pipeline, and commercialization strategies; competitor threat analyses; and profiles of the top 25 competitors and products.
- Ongoing Secondary Monitoring and Alerts
Sedulo implemented proactive tracking and an alert notification system covering developments, regulatory filings, commercial activity, go-to-market strategies, messaging and positioning, portfolio direction, and marketing tactics. The team closely monitored regulatory actions, including potential FDA conversions or revocations of EUAs. Timely email alerts and quarterly news summaries kept stakeholders informed of high-priority and time-sensitive developments.
- Comprehensive Primary Intelligence
Sedulo leveraged its Persistent Source Network™ to engage high-value sources and fill critical knowledge gaps, validating secondary findings and uncovering deeper insights into competitor strategy and market dynamics.
- Flexible Ad Hoc Research
A dedicated bucket of hours allowed the client to address emerging questions and evolving priorities throughout the year.
The Impact
The client gained a validated, continuously updated view of the U.S. competitive landscape for lab services, POC, and self-test offerings across Respiratory and STI. Sedulo’s program enabled stronger D2C strategic planning, more confident expansion assessments, and faster response to competitor and regulatory changes, supporting informed decisions across both existing and new markets.